Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China · Delayed Price · Currency is CNY 22.10
-0.75 (-3.28%)
Mar 20, 2026, 1:35 PM CST
SHE:002393 Revenue
In the year 2025, Tianjin Lisheng Pharmaceutical had annual revenue of 1.39B CNY with 4.23% growth. Tianjin Lisheng Pharmaceutical had revenue of 385.38M in the quarter ending December 31, 2025, with 23.37% growth.
Revenue
1.39B
Revenue Growth
+4.23%
P/S Ratio
4.20
Revenue / Employee
868.24K
Employees
1,604
Market Cap
5.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.39B | 56.51M | 4.23% |
| Dec 31, 2024 | 1.34B | 183.12M | 15.88% |
| Dec 31, 2023 | 1.15B | 6.44M | 0.56% |
| Jan 1, 2023 | 1.15B | 54.65M | 5.00% |
| Jan 1, 2022 | 1.09B | -48.90M | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition